Clinical Trials Browser

Not yet recruiting × Recurrence × Nivolumab × Clear all

NCT06639607 2026-03-10

PRiME II

Phase 1/2 Not yet recruiting

Diffuse Intrinsic Pontine Glioma, Ependymoma, Medulloblastoma, Recurrence